Mechanisms such as decreased vitamin D and insulin-like growth factor-I (IGF-1), increased inflammatory mediators and fibronectin isoforms can further affect osteoblast and osteoclast function, leading to osteoporosis and an increased risk of fragility fractures [36, 37]. The gene discussed is FN1; the disease is osteoporosis.